Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide - PubMed (original) (raw)

Review

doi: 10.1038/nrm2101.

Affiliations

• PMID: 17245412
• DOI: 10.1038/nrm2101

Review

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Christian Haass et al. Nat Rev Mol Cell Biol. 2007 Feb.

Abstract

The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders. Small intermediates - soluble oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insoluble deposits might function as reservoirs of the bioactive oligomers. These emerging concepts are exemplified by Alzheimer's disease, in which amyloid beta-protein oligomers adversely affect synaptic structure and plasticity. Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.

PubMed Disclaimer

Comment in

• PTEN regulates RPA1 and protects DNA replication forks.
  Wang G, Li Y, Wang P, Liang H, Cui M, Zhu M, Guo L, Su Q, Sun Y, McNutt MA, Yin Y. Wang G, et al. Cell Res. 2015 Nov;25(11):1189-204. doi: 10.1038/cr.2015.115. Epub 2015 Sep 25. Cell Res. 2015. PMID: 26403191 Free PMC article.

Similar articles

• Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
  Gadad BS, Britton GB, Rao KS. Gadad BS, et al. J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182. J Alzheimers Dis. 2011. PMID: 21460436 Review.
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.
  Walsh DM, Selkoe DJ. Walsh DM, et al. Protein Pept Lett. 2004 Jun;11(3):213-28. doi: 10.2174/0929866043407174. Protein Pept Lett. 2004. PMID: 15182223 Review.
• Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
  Hashimoto M, Rockenstein E, Crews L, Masliah E. Hashimoto M, et al. Neuromolecular Med. 2003;4(1-2):21-36. doi: 10.1385/NMM:4:1-2:21. Neuromolecular Med. 2003. PMID: 14528050 Review.
• [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
  Tomiyama T. Tomiyama T. Brain Nerve. 2010 Jul;62(7):691-9. Brain Nerve. 2010. PMID: 20675873 Review. Japanese.
• Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
  Limbocker R, Cremades N, Cascella R, Tessier PM, Vendruscolo M, Chiti F. Limbocker R, et al. Acc Chem Res. 2023 Jun 20;56(12):1395-1405. doi: 10.1021/acs.accounts.3c00045. Epub 2023 Apr 18. Acc Chem Res. 2023. PMID: 37071750 Free PMC article.

Cited by

• Molecular mechanisms at the basis of the protective effect exerted by EPPS on neurodegeneration induced by prefibrillar amyloid oligomers.
  Zarrilli B, Bonanni R, Belfiore M, Severino M, Cariati I, Fioravanti R, Cappella G, Sennato S, Frank C, Giordani C, Tancredi V, Bombelli C, Diociaiuti M, D'Arcangelo G. Zarrilli B, et al. Sci Rep. 2024 Nov 3;14(1):26533. doi: 10.1038/s41598-024-77859-9. Sci Rep. 2024. PMID: 39489758 Free PMC article.
• Bibliometric and visual analysis of single-cell multiomics in neurodegenerative disease arrest studies.
  Wang J, Wang S, Li Q, Liu F, Wan Y, Liang H. Wang J, et al. Front Neurol. 2024 Oct 8;15:1450663. doi: 10.3389/fneur.2024.1450663. eCollection 2024. Front Neurol. 2024. PMID: 39440247 Free PMC article.
• Cognition-Associated Protein Structural Changes in a Rat Model of Aging are Related to Reduced Refolding Capacity.
  Tarbox HE, Branch A, Fried SD. Tarbox HE, et al. bioRxiv [Preprint]. 2024 Sep 24:2024.09.20.614172. doi: 10.1101/2024.09.20.614172. bioRxiv. 2024. PMID: 39386726 Free PMC article. Preprint.
• Destabilisation of Alzheimer's amyloid-β protofibrils by Baicalein: mechanistic insights from all-atom molecular dynamics simulations.
  Choudhury S, Dasmahapatra AK. Choudhury S, et al. Mol Divers. 2024 Oct 8. doi: 10.1007/s11030-024-11001-9. Online ahead of print. Mol Divers. 2024. PMID: 39379662
• Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease.
  Zota I, Chanoumidou K, Gravanis A, Charalampopoulos I. Zota I, et al. Front Cell Neurosci. 2024 Sep 2;18:1422130. doi: 10.3389/fncel.2024.1422130. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39285941 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information